Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Current Assets (2016 - 2025)

Historic Current Assets for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $29.4 billion.

  • Bristol Myers Squibb's Current Assets fell 130.96% to $29.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $29.4 billion, marking a year-over-year decrease of 130.96%. This contributed to the annual value of $29.4 billion for FY2025, which is 130.96% down from last year.
  • As of Q4 2025, Bristol Myers Squibb's Current Assets stood at $29.4 billion, which was down 130.96% from $35.6 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Current Assets registered a high of $35.6 billion during Q3 2025, and its lowest value of $26.8 billion during Q3 2022.
  • In the last 5 years, Bristol Myers Squibb's Current Assets had a median value of $29.3 billion in 2021 and averaged $29.6 billion.
  • Per our database at Business Quant, Bristol Myers Squibb's Current Assets plummeted by 1800.55% in 2022 and then surged by 2691.01% in 2025.
  • Bristol Myers Squibb's Current Assets (Quarter) stood at $33.3 billion in 2021, then fell by 18.01% to $27.3 billion in 2022, then rose by 16.49% to $31.8 billion in 2023, then decreased by 6.26% to $29.8 billion in 2024, then decreased by 1.31% to $29.4 billion in 2025.
  • Its Current Assets stands at $29.4 billion for Q4 2025, versus $35.6 billion for Q3 2025 and $33.2 billion for Q2 2025.